Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
A variant of t-PA (T103N, KHRR 296-299 AAAA) that, by bolus, has increased potency and decreased systemic activation of plasminogen.
Thromb Haemost. 1993 Aug 2;70(2):313-9.
Thromb Haemost. 1993.
PMID: 8236141
A faster-acting and more potent form of tissue plasminogen activator.
Keyt BA, Paoni NF, Refino CJ, Berleau L, Nguyen H, Chow A, Lai J, Peña L, Pater C, Ogez J, et al.
Keyt BA, et al.
Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3670-4. doi: 10.1073/pnas.91.9.3670.
Proc Natl Acad Sci U S A. 1994.
PMID: 8170967
Free PMC article.
Item in Clipboard
Pharmacokinetics, pharmacodynamics and tolerability of a potent, non-peptidic, GP IIb/IIIa receptor antagonist following multiple oral administrations of a prodrug form.
Refino CJ, Modi NB, Bullens S, Pater C, Lipari MT, Robarge K, Blackburn B, Beresini M, Weller T, Steiner B, Bunting S.
Refino CJ, et al.
Thromb Haemost. 1998 Jan;79(1):169-76.
Thromb Haemost. 1998.
PMID: 9459344
Item in Clipboard
A soluble tissue factor mutant is a selective anticoagulant and antithrombotic agent.
Kelley RF, Refino CJ, O'Connell MP, Modi N, Sehl P, Lowe D, Pater C, Bunting S.
Kelley RF, et al.
Blood. 1997 May 1;89(9):3219-27.
Blood. 1997.
PMID: 9129026
Free article.
Item in Clipboard
Cite
Cite